Literature DB >> 16618113

Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

Orsolya Polgar1, Csilla Ozvegy-Laczka, Robert W Robey, Kuniaki Morisaki, Masaki Okada, Akina Tamaki, Gabriella Koblos, N Barry Elkind, Yvona Ward, Michael Dean, Balazs Sarkadi, Susan E Bates.   

Abstract

ABCG2 is an ATP-binding cassette half-transporter conferring resistance to chemotherapeutic agents such as mitoxantrone, irinotecan, and flavopiridol. With its one transmembrane and one ATP-binding domain, ABCG2 is thought to homodimerize for function. One conserved region potentially involved in dimerization is a three-amino acid sequence in transmembrane segment 5 (residues 552-554). Mutations in the corresponding residues in the Drosophila white protein (an orthologue of ABCG2) are thought to disrupt heterodimerization. We substituted glycine 553 with leucine (G553L) followed by stable transfection in HEK 293 cells. The mutant was not detectable on the cell surface, and markedly reduced protein expression levels were observed by immunoblotting. A deficiency in N-linked glycosylation was suggested by a reduction in molecular mass compared to that of the 72 kDa wild-type ABCG2. Similar results were observed with the G553E mutant. Confocal microscopy demonstrated mostly ER localization of the G553L mutant in HEK 293 cells, even when coexpressed with the wild-type protein. Despite its altered localization, the G553L and G553E mutants were cross-linked using amine-reactive cross-linkers with multiple arm lengths, suggesting that the monomers are in the proximity of each other but are unable to complete normal trafficking. Interestingly, when expressed in Sf9 insect cells, G553L moves to the cell membrane but is unable to hydrolyze ATP or transport the Hoechst dye. Still, when coexpressed, the mutant interferes with the Hoechst transport activity of the wild-type protein. These data show that glycine 553 is important for protein trafficking and are consistent with, but do not yet prove, its involvement in ABCG2 homodimerization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618113      PMCID: PMC2548280          DOI: 10.1021/bi0521590

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; Y Hamon; G Chimini
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

2.  Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.

Authors:  Ulla Henriksen; Jacob U Fog; Thomas Litman; Ulrik Gether
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

3.  Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.

Authors:  C Ozvegy; T Litman; G Szakács; Z Nagy; S Bates; A Váradi; B Sarkadi
Journal:  Biochem Biophys Res Commun       Date:  2001-07-06       Impact factor: 3.575

4.  Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization.

Authors:  Kumie Kage; Satomi Tsukahara; Tomomi Sugiyama; Sakiyo Asada; Etsuko Ishikawa; Takashi Tsuruo; Yoshikazu Sugimoto
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

5.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

Authors:  M Maliepaard; G L Scheffer; I F Faneyte; M A van Gastelen; A C Pijnenborg; A H Schinkel; M J van De Vijver; R J Scheper; J H Schellens
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 6.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

7.  Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.

Authors:  S Kawabata; M Oka; K Shiozawa; K Tsukamoto; K Nakatomi; H Soda; M Fukuda; Y Ikegami; K Sugahara; Y Yamada; S Kamihira; L A Doyle; D D Ross; S Kohno
Journal:  Biochem Biophys Res Commun       Date:  2001-02-09       Impact factor: 3.575

8.  Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

Authors:  R W Robey; W Y Medina-Pérez; K Nishiyama; T Lahusen; K Miyake; T Litman; A M Senderowicz; D D Ross; S E Bates
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

Review 9.  Role of ABCG1 and other ABCG family members in lipid metabolism.

Authors:  G Schmitz; T Langmann; S Heimerl
Journal:  J Lipid Res       Date:  2001-10       Impact factor: 5.922

10.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters.

Authors:  G Chang; C B Roth
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

View more
  10 in total

1.  Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.

Authors:  Takashi Sugiyama; Tsuyoshi Shuto; Shingo Suzuki; Takashi Sato; Tomoaki Koga; Mary Ann Suico; Hiroyuki Kusuhara; Yuichi Sugiyama; Douglas M Cyr; Hirofumi Kai
Journal:  Biochem Biophys Res Commun       Date:  2010-12-22       Impact factor: 3.575

Review 2.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

3.  The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.

Authors:  Mark F Rosenberg; Zsolt Bikadi; Janice Chan; Xiaoping Liu; Zhanglin Ni; Xiaokun Cai; Robert C Ford; Qingcheng Mao
Journal:  Structure       Date:  2010-03-14       Impact factor: 5.006

4.  Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.

Authors:  Xiaokun Cai; Zsolt Bikadi; Zhanglin Ni; Eun-Woo Lee; Honggang Wang; Mark F Rosenberg; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2010-03-04       Impact factor: 4.030

5.  ABCG2 transports and transfers heme to albumin through its large extracellular loop.

Authors:  Elodie Desuzinges-Mandon; Ophélie Arnaud; Lorena Martinez; Frédéric Huché; Attilio Di Pietro; Pierre Falson
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

6.  Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.

Authors:  Orsolya Polgar; Caterina Ierano; Akina Tamaki; Bradford Stanley; Yvona Ward; Di Xia; Nadya Tarasova; Robert W Robey; Susan E Bates
Journal:  Biochemistry       Date:  2010-03-16       Impact factor: 3.162

7.  Arginine 383 is a crucial residue in ABCG2 biogenesis.

Authors:  Orsolya Polgar; Lilangi S Ediriwickrema; Robert W Robey; Ajay Sharma; Ramanujan S Hegde; Yongfu Li; Di Xia; Yvona Ward; Michael Dean; Csilla Ozvegy-Laczka; Balazs Sarkadi; Susan E Bates
Journal:  Biochim Biophys Acta       Date:  2009-05-03

Review 8.  ABCG2: a perspective.

Authors:  Robert W Robey; Kenneth K K To; Orsolya Polgar; Marius Dohse; Patricia Fetsch; Michael Dean; Susan E Bates
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

9.  Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence.

Authors:  Honggang Wang; Eun-Woo Lee; Xiaokun Cai; Zhanglin Ni; Lin Zhou; Qingcheng Mao
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

10.  Dimerization of ABCG2 analysed by bimolecular fluorescence complementation.

Authors:  Ameena J Haider; Deborah Briggs; Tim J Self; Hannah L Chilvers; Nicholas D Holliday; Ian D Kerr
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.